STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Insulet Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Insulet Corporation (PODD) Form 144 notifies of a proposed sale of 687 common shares through Fidelity Brokerage Services with an aggregate market value of $238,718.01, planned for 09/08/2025 on NASDAQ. The shares were acquired by the filer via restricted stock vesting as compensation on 01/10/2025 (308 shares) and 02/27/2025 (379 shares).

The filing also discloses prior sales by the same person, Prem Singh: 2,327 shares sold on 06/13/2025 for $698,216.35 and 1,343 shares sold on 08/07/2025 for $429,760.00. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.

Positive
  • Transparency: The filing discloses acquisition dates, nature of acquisition, broker, planned sale date, and past sales, meeting Rule 144 reporting requirements
  • Compensation origin: Shares to be sold were acquired via restricted stock vesting, indicating they resulted from issuer compensation rather than external purchase
Negative
  • Insider sales: The filer has sold 3,670 shares in the past three months, which may be interpreted by some investors as disposition of holdings
  • No 10b5-1 plan disclosed: The filing does not indicate adoption of a written trading plan or date, so sales may be viewed as discretionary

Insights

TL;DR: Routine insider sale notice showing vested restricted shares proposed for sale; prior voluntary sales also disclosed.

This Form 144 documents a planned open-market sale of 687 vested shares valued at $238,718.01, consistent with compensation-related share vesting earlier in 2025. The filing is procedural and provides transparency about timing, broker, and past sales by the same person totaling 3,670 shares in the last three months. There is no additional financial or operational disclosure in this filing to assess company fundamentals.

TL;DR: Filing appears to meet Rule 144 disclosure requirements and includes the seller's attestation about material information.

The notice identifies acquisition dates, nature of acquisition (restricted stock vesting), payment as compensation, broker details, and past sales with gross proceeds, fulfilling key Rule 144 reporting elements. The seller's signature block includes the standard representation regarding knowledge of undisclosed material adverse information, as required for compliance. No indication of a 10b5-1 plan is provided in the content.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for PODD disclose about the proposed sale?

The form discloses a proposed sale of 687 common shares through Fidelity on 09/08/2025 with an aggregate market value of $238,718.01 on NASDAQ.

How were the shares being sold by the filer acquired?

The shares were acquired via restricted stock vesting from the issuer: 308 shares on 01/10/2025 and 379 shares on 02/27/2025, recorded as compensation.

Has the filer sold other Insulet (PODD) shares recently?

Yes. Prem Singh sold 2,327 shares on 06/13/2025 for $698,216.35 and 1,343 shares on 08/07/2025 for $429,760.00.

Which broker is handling the proposed sale?

The proposed sale lists Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917 as the broker.

Does the filing include the seller's attestation about material information?

Yes. The notice includes the standard representation that the seller does not know of any undisclosed material adverse information regarding the issuer.
Insulet Corp

NASDAQ:PODD

PODD Rankings

PODD Latest News

PODD Latest SEC Filings

PODD Stock Data

22.76B
70.12M
0.27%
101.79%
2.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON